Impact of hepatitis B immunoglobulin mode of administration on treatment experiences of patients after liver transplantation: Results from an online survey

Figure 3 Satisfaction with current hepatitis B immunoglobulin treatment. Percentages are rounded to the nearest whole numbers therefore may not add up to 100% for each column. ^aP ≤ 0.05 denotes statistically significant difference vs intravenous hepatitis B immunoglobulin. ¹Percentages calculated as a proportion of 89 patients who responded to this question. ²Percentages calculated as a proportion of 45 patients who responded to this question. HBIG: Hepatitis B immunoglobulin; IM: Intramuscular; IV: Intravenous; SC: Subcutaneous.